Verseon Corporation Additional Listing & Total Voting Rights (3328Z)
August 31 2018 - 1:00AM
UK Regulatory
TIDMVSN
RNS Number : 3328Z
Verseon Corporation
31 August 2018
August 31, 2018
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 4,375 new
shares of common stock ("Common Shares") of par value US$0.001 each
to be admitted to trading on AIM pursuant to regularly scheduled
vesting of restricted stock units (the "Issuance").
The 4,375 new Common Shares issued pursuant to the Issuance will
rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on September
5, 2018 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 151,622,417 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 151,579,500. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
For further information, please contact:
Verseon Corporation www.verseon.com
Sebastian Wykeham +1 (510) 225 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Paul Shackleton / Maria +44 (0) 20 7614
Gomez De Olea 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Marc Milmo / Phil Davies / Callum Butterfield 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEAFPEDELPEAF
(END) Dow Jones Newswires
August 31, 2018 02:00 ET (06:00 GMT)
Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2024 to May 2024
Verseon (LSE:VSN)
Historical Stock Chart
From May 2023 to May 2024